Authors


Aliènne Salleroli, MS, BSN, RN, OCN.

Latest:

Aliènne Salleroli on Starting the DEI Conversation in Oncology Nursing

Aliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.


Michelle Mollica, PhD, MPH, RN, OCN

Latest:

Michelle Mollica on Individualizing Care Plans for Cancer Survivors

Michelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.


Jennifer R. Green, MD

Latest:

Bring A Nuanced Approach to Venous Thromboembolism Management

Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.


Kara Morris, MSN, RN, OCN

Latest:

Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast Cancer

Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.


Elizabeth Aronson, MSN, FNP-BCN, OCN

Latest:

Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in Multiple Myeloma

Elizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.


Huntsman Cancer Institute at the University of Utah

Latest:

Five Researchers Awarded Pilot Project Funding

Every year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.


Sarah Montini, BSN, RN, OCN

Latest:

Rx Road Map: Abemaciclib (Verzenio)

Sarah Montini, BSN, RN, OCN, provides an in-depth look at abemaciclib for the treatment of patients with breast cancer in a downloadable reference sheet.



Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP

Latest:

Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing Radiation

Hilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.


Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Hannah Clarke

Latest:

Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC

The median overall survival with niraparib, abiraterone acetate, and prednisone was 30.4 months vs 28.6 months with abiraterone acetate and prednisone alone.


Melanie Darvish, BSN, RN

Latest:

Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology Nurse

Melanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.


David Hui, MD, MSc

Latest:

Many Patients Are Under-Sedated During End-of-Life Cancer Care

David Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.


Karyn A. Goodman, MD, MS

Latest:

Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer

Karyn A. Goodman, MD, MS, provides perspective on the potential advantages of stereotactic body radiation therapy in locally advanced pancreatic cancer.


John Lewandowski, PA-C, MS

Latest:

A Multidisciplinary Approach Improves a Patient’s Experience With Colon Cancer

Early coordination with multiple specialty teams can maximize outcomes and improve quality of life for patients with complex metastatic disease.


Estelamari Rodriguez, MD

Latest:

How I Counsel Patients About Lung Cancer Screening

A lung cancer screening navigator offers their perspective on shared decision-making.


Sherry Adkins, MSN, ANP-C

Latest:

Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell Therapy

Sherry Adkins, MSN, ANP-C, discusses some key considerations in ensuring quality patient care after they have completed CAR T-cell therapy at a specialized center.


Matthew Goetz, MD

Latest:

Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast Cancer

Grace Choong, MD; and Matthew Goetz, MD, discuss the effect of omitting adjuvant endocrine therapy for patients with estrogen receptor–positive breast cancer who were treated with neoadjuvant chemotherapy.


Ashley B. Johnson, MSN, APRN, FNP-C

Latest:

Considerations for Premenopausal Women With TNBC

Triple-negative breast cancer often occurs in women younger than 40.


Sarah Low, RN, MSN, OCN, CMSRN

Latest:

Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient Ambulation

Sarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.


Brianna Lutz, MSN, RN, OCN

Latest:

Brianna Lutz on How to Improve Nurse Responsiveness on an Inpatient Oncology Unit

Brianna Lutz, MSN, RN, OCN, discusses a red-and-green dot hourly column that shows which patients with cancer have been attended to in the past hour.


Kelley A. Rone, DNP, RN, AGNP-c

Latest:

Kelley Rone on the Evolving Role of Immunotherapy in GI Cancers

Kelley A. Rone, DNP, RN, AGNP-c, discusses the advantages associated with immunotherapy in the treatment of patients with gastrointestinal cancers.


Courtney Flaherty

Latest:

Consolidation Durvalumab Improves Survival in Limited Stage SCLC

Durvalumab monotherapy as consolidation therapy in limited-stage small cell lung cancer produced a clinical benefit in patients from the phase 3 ADRIATIC trial.


University of Arizona Cancer Center

Latest:

Cancer Center gets $1.1M gift for holistic cancer care

The gift is from the estate of Tom and Catherine Culley, longtime residents of the East Coast and worldwide travelers.


Medically reviewed by: Stacey Abels, PhD

Latest:

Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)

Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.


Charles E. Geyer, MD, FACP

Latest:

Dr. Geyer Highlights Optimal Dosing Strategies for New Olaparib Indication in Breast Cancer

Charles E. Geyer, MD, FACP, discusses dosing strategies and adverse event management with olaparib.


Melisa Celikoyar, LCSW

Latest:

Opinion: Wilderness Therapy Offers Benefits to Patients With Cancer

Wilderness therapy is a nontraditional form of therapy that uses components of exposure to outdoor activity and mental health treatment.


Kimberly A. Spickes, CNP

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.


Janelle Wagner, RN, OCN

Latest:

Setting Boundaries Can Be a Challenge for Nurse Navigators

Janelle Wagner, RN, OCN, Senior Manager of Patient Navigation Program for Community Sites, highlights some challenges commonly associated with nurse navigation, and how nurses can overcome them.


Kate Sandstrom, MSN, APRN-BC, AOCN

Latest:

Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology Teams

Kate Sandstrom, MSN, APRN-BC, AOCN, discusses the importance of including the radiation oncology team in a patient’s long-term care plan.

© 2024 MJH Life Sciences

All rights reserved.